Open AccessCommunity-acquired pneumonia in elderly patients: the effectiveness of antimicrobial therapy regimens.
Author(s) -
И. Ц. Кулагина,
V I Likhodii,
А. А. Зайцев
Publication year - 2019
Publication title -
vestnik rossijskoj voenno-medicinskoj akademii
Language(s) - English
Resource type - Journals
eISSN - 2687-1424
pISSN - 1682-7392
DOI - 10.17816/brmma20686
Subject(s) - medicine , community acquired pneumonia , amoxicillin , pneumonia , sulbactam , radiological weapon , intensive care medicine , antibiotics , antimicrobial , surgery , antibiotic resistance , chemistry , organic chemistry , imipenem , microbiology and biotechnology , biology
The clinical efficacy of using «protected» aminopenicillins (amoxicillin/clavulanate, amoxicillin/sulbactam) and the 3rd generation cephalosporins in the treatment of mild community-acquired pneumonia in patients older than 60 years in hospital has been evaluated. Analyzed 71 case histories. The assessment was carried out on the basis of a comprehensive analysis of clinical, laboratory and radiological data. A comparative analysis of the clinical efficacy and safety of the antibiotic regimens under study demonstrated the obvious advantage of using «protected» aminopenicillins over the existing practice of treating non-severe community-acquired pneumonia in patients of older age groups.